ASH 2018 | AML highlights from ASH 2018
Guillermo Garcia-Manero
Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, delivers key highlights, including exciting trials, future outlooks, and developments in the field of acute myeloid leukemia (AML) from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.
Related videos
2:11
An exciting era for CAR T-cell therapy
Mohamad Mohty
2:11
Anti-CD19 CAR T-cell therapy in combination with ibrutinib for CLL/SLL
Saar Gill
2:11
Ibrutinib combinations for CLL: iLLUMINATE results & more
Carol Moreno
2:11
JCAR017 for relapsed/refractory CLL
Tanya Siddiqi
2:11
Factors that influence the treatment decision-making of CLL patients
Brian Koffman
